Trial Profile
The retrospective study assessing population characteristics and utilization patterns of patients treated with palbociclib.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jan 2018 New trial record
- 09 Dec 2017 Results assessing population characteristics and utilization patterns of patients treated with palbociclib over 2 years of post-approval were, presented at the 40th Annual San Antonio Breast Cancer Symposium.